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Abstract
The assisted reproductive technologies (ARTs) have been used in the production of rhesus monkey
offspring at the Oregon National Primate Research Center (ONPRC) and that experience is
summarized here. Additionally these technologies serve as a source of oocytes/embryos for
monozygotic twinning, embryonic stem (ES) cell derivation and cloning. High fertilization
efficiencies were realized with conventional insemination or following the use of intracytoplasmic
sperm injection (ICSI) and approximately 50% of the resulting embryos grew in vitro to blastocysts.
Both fresh and frozen sperm were employed in fertilization by ICSI and the resulting embryos could
be low temperature stored for subsequent thawing and transfer when a synchronized recipient
female was available or after shipment to another facility. Following the transfer of up to 3 embryos,
an overall pregnancy rate of 30% was achieved with increasing rates dependent upon the number
of embryos transferred. Singleton pregnancy outcomes following the transfer of ART produced
embryos were similar to those observed in a control group of animals in the timed mated breeding
colony at ONPRC. ICSI produced embryos were used in efforts to create monozygotic twins by
blastomere separation or blastocyst splitting. While pregnancies were achieved following the
transfer of demi-embryos, only one was a twin and it was lost to spontaneous abortion. ICSI
produced embryos have also served as the source of blastocysts for the derivation of embryonic
stem cells. These pluripotent cells hold potential for cell based therapies and we consider the
monkey an important translational model in which to evaluate safety, efficacy and feasibility of
regenerative medicine approaches based on the transplantation of stem cell-derived progeny.
Finally, efforts to produce genetically-identical monkeys by nuclear transfer have been briefly
summarized.
Review
Notable progress has been realized in the past 20 years in
both the development and application of the ARTs in
monkeys with advances in ovarian follicular stimulation,
fertilization by intractyoplasmic sperm injection (ICSI),
culture medium development for the production of blast-
ocysts, low temperature storage of sperm and embryos
and embryo manipulation including twinning, cloning
and the derivation of embryonic stem cells. Unlike in
many fields where knowledge flows from non-human pri-
mate (NHP) research to clinical application in humans,
the development of the ARTs in monkeys historically
postdates human application. The experience in NHP,
however, while nowhere nearly as robust as that in
humans has been associated with several landmark
accomplishments and methods for establishing pregnan-
cies are currently available as summarized by us in 2001
[1]. While a few reports in New World monkeys and Great
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Apes exist, most research efforts have focused on Old
World macaques with the rhesus monkey the primary
subject and that species is the focus of this review.
The first successful birth of a rhesus macaque following
IVF was reported in 1984 by Bavister and coworkers [2]
and the total number of infants born to date is approxi-
mately one hundred. Development of the ARTs in NHPs
has been impacted by resource availability, high expense
and lack of compelling incentives to produce large num-
bers of monkeys using this approach. The latter limitation
has recently been eliminated by the need for Indian-ori-
gin, rhesus macaques carrying the class 1 MHC allele,
A*01 for HIV vaccine development research [3] (Figure
1). In addition to this demand for specific genotypes,
many experimental paradigms could benefit from the
availability of genetically-identical animals produced by
monozygotic twinning or by somatic or ES cell cloning.
Finally, development of cell-based therapies for the treat-
ment of disease has gained momentum and a great deal of
attention predicated on the availability of stem cells
including those isolated from the blastocyst.
While application of the ARTs results in the production of
embryos and pregnancies following transfer, information
on pregnancy outcome is prerequisite to evaluating the
impact of the ARTs on routine animal husbandry and
more exotic applications such as the preservation of
Schematic presentation of our approach to producing mamu A*01 positive rhesus monkey offspring Figure 1
Schematic presentation of our approach to producing mamu A*01 positive rhesus monkey offspring. Sperm 
were acquired from an A*01-positive, homozygous male housed at the New England National Primate Research Center, fro-
zen and shipped to ONPRC. Subsequent fertilization by ICSI produced heterozygous mamu A*01 offspring if the oocyte donor 
was mamu A*01 negative (over 80% of the colony at ONPRC) or 50% homozygous and 50% heterozygous if the oocyte donor 
was heterozygous for the mamu A*01 allele. We have now produced in excess of 30 offspring using this approach. Infants have 
also resulted from transfers of frozen-thawed embryos produced in Oregon and shipped to New England.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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endangered species. The monkey can also serve as a model
for clinical application of the ARTs where fertilization by
ICSI has been associated with an increased frequency of
genetic problems that may be secondary to the inappro-
priate expression of imprinted genes [4,5]. In nonprimate
animals, a large offspring syndrome [6] has been associ-
ated with in vitro manipulation of embryos and while this
does not appear to be a problem in ART produced chil-
dren, its possible existence in NHPs has not been
evaluated.
This chapter will summarize the experience at ONPRC
with the ARTs in the rhesus monkey building on two pre-
vious reviews [1,7]. The methodology employed in the
conduction of the ARTs in monkeys can also be found in
these reviews. My objective is to disseminate the results of
our extensive experience in the rhesus macaque in an
effort to catalyze research using non-human primates.
Oocyte collection, fertilization and embryo 
culture
Oocyte recovery from adult, cycling rhesus monkeys sub-
jected to controlled ovarian stimulation has been
described previously [1] and reviewed in the contribution
by Drs. Stouffer and Zelinski-Wooten. The percentage of
oocytes recovered at the mature, fertilizable MII stage var-
ies as a function of the hCG to egg collection time between
27 and 36 hr [8]. Experiments requiring enucleation are
ideally conducted immediately after 1st polar body extru-
sion in which case a shorter time interval such as 27 hr is
ideal. Oocytes that are recovered as metaphase I (MI) at
the 27 hr interval can be monitored in vitro for release of
the first polar body and used promptly thereafter. On the
other hand, for routine fertilization, it is usually prefera-
ble to recover the maximum number of oocytes at the MII
stage, in which case the hCG to collection interval can be
lengthened to 33–34 hr. The number of oocytes collected
following controlled ovarian stimulation in our experi-
ence is high, averaging 38 ± 2 [7]. Although not all are
healthy, fertilizable oocytes, this number is considerably
higher than that associated with the ARTs in women
where a focus on the collection of approximately 10 high
quality oocytes is becoming the norm [9]. This difference,
along with the use of fixed length stimulation protocols,
may be relevant to our efforts to improve ART outcomes
in monkeys. A discussion of oocyte quantity and quality
in the monkey can be found in the contribution by Drs.
Stouffer and Zelinski-Wooten.
The conventional approach to embryo production using
the ARTs is IVF and we reported a 61 ± 6% fertilization
rate for 23 replicates involving 242 ova [7]. In our hands,
complications associated with agglutination following
sperm exposure to the capacitating agents, dibutyrylcyclic
adenosine monophosphate and caffeine [10], are signifi-
cant and we have, therefore, adopted ICSI as our routine
insemination procedure. Similar if not improved out-
comes have been experienced with fresh sperm ICSI, 81 ±
3% for 61 replicates and 714 ova, however, we do not
know if the use of ICSI creates problems with regards the
transmission of genetic disease or the production of sub-
optimal embryos. An evaluation would require the direct
comparison of pregnancy rates obtained with IVF versus
ICSI-produced embryos as well as long-term follow up on
the offspring.
In general, conventional IVF is not feasible with frozen
thawed sperm because of the rapid motility loss that
occurs post-thaw [7]. However, control, fresh sperm ferti-
lization rates can be achieved with cryopreserved sperm
when ICSI is conducted 3 or more hours after sperm thaw-
ing and cryoprotectant removal. This delay presumably
reflects the need for a post-thaw recovery period and res-
toration of the sperm's oocyte activating potential.
A complex medium, CMRL 1066 supplemented with
serum, has historically been used to culture NHP embryos
[11,12]. In early trials, coculture on buffalo rat liver cell
monolayers in the presence of CMRL 1066 produced the
highest blastocyst development rate [13]. However, while
coculture may improve developmental potential, its com-
plexity makes the specific requirements for development
in vitro difficult, if not impossible to study, not to mention
the probable variability inherent in the coculture system.
Attempts to culture embryos in a chemically defined
medium (KSOM/AA) supplemented with serum resulted
in improved, but inconsistent in vitro development rates
[14]. Parenthetically, sequential media developed for
human IVF such as G1/G2 have not produced satisfactory
results in the monkey (unpublished). Recently, we initi-
ated the use of HECM-9 in the absence of coculture [15-
17] and reported a 76 ± 2% ICSI fertilization rate and a 47
± 4% blastocyst formation rate [7]. Embryo culture in
HECM-9 produced faster development than in CMRL/BRL
or KSOM-AA with compact morulae present on day 3, cav-
itating blastocysts on day 5 and expanded blastocysts on
day 7 (Figure 2). The rates reported here for HECM-9 may
closely approximate the in vivo rates although the latter are
based on the recovery and staging of a limited number of
embryos flushed from the uterus [see Figure 2;
[12,14,18]]. A retrospective comparison of pregnancy and
implantation rates for embryos produced in these in vitro
systems indicated similar results when embryo transfers
were conducted with early stage (days 2–4) cleaving
embryos. For CMRL/BRL produced embryos, 24 pregnan-
cies were obtained in 96 transfers (25%) and for HECM-9
produced embryos, 20 pregnancies resulted from 77
transfers (26%) [7].Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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Embryo transfer
Parameters known to contribute to pregnancy and
implantation rates following embryo transfer to synchro-
nized recipients include the number of embryos trans-
ferred, embryo quality and the method of transfer. When
increasing numbers of embryos were transferred up to 3,
a corresponding increase in pregnancy rate to 36% was
realized and implantation rates when expressed per
embryo were independent of the number of embryos
transferred. However, these databases are not yet large
enough to establish statistical significance [7]. Recently we
experienced the first triplet pregnancy reported in rhesus
monkeys that occurred following the transfer of 3 frozen-
thawed embryos. The pregnancy terminated spontane-
ously at 85 days possibly following intrauterine demise of
the smallest member of the triplet set (Male, 0.067 kg;
Female, 0.060 kg; Male,0.033 kg).
The ability to cryostore embryos and conduct transfers
when recipients are available is essential to any wide-
spread use of the ARTs in monkeys. In our experience,
pregnancy and implantation rates for fresh and frozen-
thawed ICSI produced embryos were associated with sim-
ilar outcomes at approximately 30%. However, while the
average number of embryos transferred was comparable
for fresh (2.3) and frozen (2.1) embryos, substantial
embryo loss (35%) was associated with freeze-thawing.
The conventional approach to embryo transfer (ET) in
rhesus monkeys involves mini-laparotomy with a preg-
nancy rate of 27% (25/92) [7]. In order to avoid a surgical
procedure, it would be ideal to conduct non-surgical ET
with embryo deposition directly into the uterus, similar to
the approach currently employed in women. However,
the results to date in monkeys have been disappointing
reflecting in part difficulty in passing the long tortuous
cervix in this species. Laparoscopic ET with oviductal
placement of embryos is the most recent variation devel-
oped by Dr. John Fanton and the surgical team at ONPRC
(Figure 3). Similar pregnancy and implantation results
were obtained when mini-laparotomy was compared to
laparoscopy and since laparoscopy avoids exposure of the
animal to a major surgery, that technique is now preferred
by us. Preliminary evidence suggests that embryos at any
Average time in days for ART-produced embryos to reach a given developmental stage Figure 2
Average time in days for ART-produced embryos to reach a given developmental stage. Embryos were cultured 
in CMRL/BRL (yellow triangles), KSOM-AA supplemented with 10% fetal calf serum (pink squares) or HECM-9 with albumin 
(blue diamonds). M, morula; B, blastocyst; XB, expanded blastocyst. The results for CMRL/BRL coculture and KSOM-AA came 
from Weston and Wolf [14] and the embryos were produced by IVF while for culture in HECM-9, the results are from Wolf 
and coauthors [7] with the embryos produced by ISCI. Estimated in vivo developmental rates (open circles) have been included 
for reference purposes [12].
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stage of preimplantation development from 2-cell to
expanded blastocyst can be transferred to the oviduct with
pregnancy production.
The pregnancy success rate depends on the synchrony
between the age of the transferred embryos, as measured
by culture time in vitro, and the host endometrium, rela-
tive to the predicted day of ovulation. Synchronous trans-
fers appear to be optimal in women. However, evidence
supports an asynchronous transfer in the rhesus monkey
[19,20] with optimal timing for blastocyst (day 7/8) trans-
fer into a day 4 uterine environment. This may reflect a
retarded rate of development of embryos in vitro. In con-
trast, younger cleavage stage embryos were optimally
transferred into synchronized recipients with the highest
success rates following the transfer of day 3 embryos into
either day 2,3 or 4 recipients.
Finally, pregnancy success rate is likely also to be a func-
tion of the psychological and physical health of the recip-
ient. Thus, we have long suspected that imported Chinese
rhesus monkeys are inferior to home grown, Indian ori-
gin, rhesus macaques as recipients, because the imported
animals may not be as physically healthy and are at
increased risk for poor psychological health. However, a
retrospective review of embryo transfer did not support a
statistically significance difference between the two with
13 of 59 (22%) transfers resulting in pregnancy in Chi-
nese rhesus recipients and 35 of 132 (26%) for Indian-ori-
gin animals.
Oocyte/embryo manipulation
ART applications as described so far in this review, where
ICSI has been used to compensate for poor motility in fro-
zen-thawed sperm preparations, can also be extrapolated
to the oocyte. Conventional IVF is a poor choice for ferti-
lizing oocytes following extensive culture when zona
hardening is a likely outcome. For instance, in cases were
oocytes are matured in vitro. Another example is in the
context of preserving fertility in young cancer survivors
[21]. The strategy that we recently employed in the mon-
key model involved heterotropic transplantation of fresh
ovarian tissue followed by oocyte recovery from the grafts.
ICSI was then employed to fertilize these oocytes and the
transfer of the resulting embryos resulted in the produc-
tion of a pregnancy.
Somatic cell cloning (SCC) is perhaps the ideal approach
to producing genetically identical animals because the
clone size is, in theory, infinite. Protocols for SCC have
been developed for a number of mammalian species and
each appears to require species unique modifications to
succeed [22,23]. Cloned animal production rates are for
the most part still very low except in widely studied spe-
cies such as cattle where live birth rates in the 15–20%
Illustrations of the progressive stages in laparoscopic embryo  transfer in rhesus monkeys Figure 3
Illustrations of the progressive stages in laparoscopic 
embryo transfer in rhesus monkeys. In Panel A, the fim-
brium is grasped with a Patton retractor and placed in trac-
tion. A guide cannula is then introduced into the oviduct 
(Panel B). Finally the loaded transfer catheter is inserted 
transabdominally and advanced into the oviduct 1–3 cm in 
preparation for embryo deposition (Panel C).Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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range are now realized [Andras Dinnyes, personal com-
munication]. This increased rate in part reflects greater
attention to fetal and neonatal monitoring with cloned
pregnancies considered at high risk. The high fetal and
neonatal wastage that is associated with SCC is thought to
reflect incomplete reprogramming of the donor nucleus,
perhaps secondary to the inappropriate expression of
imprinted genes. Reprogramming is, of course, a bigger
challenge when somatic cells are employed as the donor
nuclei as opposed to relatively undifferentiated, embry-
onic cells. In fact, cloning success was first achieved in
sheep with embryonic blastomeres or cell lines derived
from embryonic cells. In monkeys, we began efforts to
produce animals by nuclear transfer before SCC was con-
sidered feasible and were successful. Initially in 1997 [24],
3 pregnancies were achieved culminating in 2 live births
in 9 embryo transfers. We repeated this success in 2002,
with one term pregnancy in 11 embryo transfers, how-
ever, the fetus was lost as a stillborn. The most likely cause
of death was fetal asphyxia and since no gross abnormal-
ities were observed, we concluded that fetal demise was
unrelated to the nuclear transfer process [25]. A number
of variables have now been studied in the context of SCC
in monkeys, however, we have not yet been successful in
achieving a clinical pregnancy. Reconstructed embryos
often grow in vitro to the morula stage but seldom to the
blastocyst and we have no independent confirmation that
the embryonic genome is actived in these cloned
embryos. Since oocyte enucleation to produce the cyto-
plast, donor cell/nucleus fusion or injection to produce a
reconstructed embryo, and chemical activation of devel-
opment is common to both embryonic and SCC, we have
concluded that the failure of SCC in the monkey is related
to incomplete reprogramming of the somatic cell nucleus.
This conclusion differs markedly from a recent report that
cloning in primates [26] is precluded by the inadvertent
removal of critical spindle related factors during enuclea-
tion. Moreover, successful therapeutic cloning in humans,
would also argue against the concept that SCC is impossi-
ble in primates [27]. In order to follow up on our hypoth-
esis that SCC is related to incomplete reprogramming, we
have renewed our efforts to clone from monkey ES cells
because these cells are relatively undifferentiated while
still available in unlimited numbers supporting the even-
tual production of large numbers of genetically-identical,
cloned animals.
In the absence of a successful protocol for SCC in mon-
keys, the need for genetically identical animals can be, at
least, partly satisfied by producing identical twins. How-
ever, the twin rate in macaques is very low at 0.05% and
is associated with poor outcomes [28]. Despite this low
twinning rate in nature, when 2 ART produced embryos
were transferred, the pregnancy rate was 25% (Table 1, top
row) and the twinning rate was 20%. The latter statistic,
with a different denominator, was derived when all preg-
nancies produced following transfer of 2 or 3 embryos
were considered. A 64% live birth rate was obtained.
Therefore, it would seem reasonable, despite the reluc-
tance of free-ranging animals to carry twins to term, that
monozygotic twins could be produced following transfer
of ART produced demi-embryos. Two approaches to
monozygotic twinning; blastomere separation and blasto-
cyst bisection have been considered [29]. Demi-embryo
pairs were produced in high efficiency by both methods
and shown to be capable of growth to blastocysts in vitro
similar to intact controls or able to re-expand following
manipulation as in the case of blastocyst-derived, demi-
embryos. Differential cell counts indicated that demi-
embryos contained one half the total number of cells of
their intact counterparts with no change in the ratios of
ICM/trophectoderm or ICM to total cells. However, when
demi-embryo sets were transferred into recipients, the
pregnancy rate was similar to that obtained following the
transfer of two intact embryos (Table 1, bottom row) but
no term twin pregnancies were realized. Despite these dis-
appointing preliminary results, we are continuing efforts
to produce monozygotic twins by these approaches.
Primate embryonic stem cell lines were first generated in
rhesus monkeys and marmosets in 1995 [30] and 1996
[31] respectively, followed by the human in 1998 [32]
and the cynomolgus macaque in 2001 [33]. A parthenog-
enote ES cell is also available in the cynomolgus monkey
[34]. Derivation of ES cell lines requires dissociation of
ICM from trophoblast at the blastocyst stage with culture
of the ICM on feeder layers of mitotically-inactivated,
mouse embryonic fibroblasts (Figure 4). Initial success in
the rhesus monkey by Thomson and colleagues [30]
Table 1: Twin pregnancy rates and outcomes in rhesus monkeys following the transfer of intact or demi-embryos.
Pregnancy rate per transfer (%) Twinning rate per transfer (%) Live birth rate per twin pregnancy (%)
Intract-embryos 14/57 (25) 14/70 (20) 18/28 (64)
Demi-embryos 12/55 (27) 1/12 (8) 0/2 (0)
The pregnancy rate was determined from transfers involving only two embryos. The twinning rate was based on all pregnancies (2 or more 
embryos/transfer) in the intact embryo group, hence the number of pregnancies is larger.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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employed in vivo produced blastocysts recovered in uter-
ine flushings. More recently, our group at ONPRC has
developed a series of ES cell lines from in vitro produced,
ICSI fertilized embryos. The availability of a stem cell
bank comprised of 25 or so well characterized lines is cru-
cial to future experimentation and an evaluation of ES cell
line specificity. We envision the NHP as an essential trans-
lational model required in efforts to bring ES cell-based
therapies to clinical trials in human patients.
Pregnancy and pregnancy outcome
We recently reviewed the outcome of 87 ART-produced
pregnancies, 14 of which were twin gestations [7]. A pop-
ulation of pregnancies from the timed mated breeding
colony was included as a gold standard for comparative
purposes. In total, 234 of 257 (91%) clinical pregnancies
resulted in live birth. In the TMB population, 14 cases of
fetal demise were recorded for a 92.5% live birth rate. This
value compared favorably with a live birth rate for an
indoor TMB rhesus colony at the California Primate
Center of 83% (1106/1332) [28].
For ART produced, singleton pregnancies (nuclear trans-
fer, demi-embryos, ICSI and IVF combined; Table 2) 63 of
72 resulted in a live birth for a rate of 87.5%, statistically
identical to the TMB population. When ART produced
pregnancies were evaluated separately, ICSI and IVF, gave
a combined live birth rate of 92.8 % (52/56), while preg-
nancy outcomes resulting from demi-embryo transfers
were significantly lower at 69% (9/13). This impaired out-
come with demi-embryos, although preliminary, suggests
that despite appearances (high in vitro development rates
to the blastocyst stage, ICM to total cell numbers similar
Schematic representation of the derivation of monkey embryonic stem cells Figure 4
Schematic representation of the derivation of monkey embryonic stem cells. ART-produced embryos are cultured 
to the expanded blastocyst stage before the trophectoderm is selectively lysed by immunosurgery. The ICM is recovered and 
cultured on mitotically-inactivated, mouse fetal fibroblasts. Epithelial outgrowths are harvested and dissociated before replating 
on the coculture. Eventually, ES cell colonies emerge that are selected, expanded and eventually subcloned before characteriza-
tion [29].Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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to intact controls), demi-embryos are not the same as
their intact counterparts.
The sex ratios of ART produced pregnancies were the same
as those for the TMB colony as were the gestational
lengths and birth weights of singleton, live, term infants.
The average twin birth weight was 0.37 kg with an average
gestational age of only 150.7 days, in both cases signifi-
cantly different from the corresponding singleton value.
Growth rates based on animal weight for singleton and
twin pregnancies are plotted in Figure 5. Offspring pro-
duced in twin pregnancies were significantly lower in
average weight until 1 year of age. Interestingly, despite
fetal wastage in multiple pregnancies the outcome of twin
pregnancies to date has resulted in the production of an
increased number of viable infants with 15 twin
pregnancies confirmed as clinically viable producing 18
live, term monkeys.
Conclusions
In the past 15 years, research into and practice of the ARTs
in rhesus monkeys at ONPRC has resulted in a number of
notable accomplishments. In 1988, the first was monkey
produced following the transfer of an embryo that had
been frozen, cryobanked and thawed after successful in
vitro fertilization. This effort has also achieved the first
twin pregnancies in rhesus monkeys, the first non-human
primate infants produced by nuclear transfer of embry-
onic cells, the first rhesus monkey infant born following
the transfer of an ICSI-produced blastocyst employing a
non-surgical procedure, the first monkey live birth result-
ing from the transfer of a demi-embryo created by blast-
omere separation at the 2-cell stage or blastocyst bisection
and the first infants produced following laparoscopic
embryo transfer. Recently we reported the outcomes of 87
pregnancies (7).
Based on the results summarized in this mini-review, the
ARTs in non-human primates would now seem to be
ready for widespread application in the propagation of
selected, desirable genotypes. This is not to say that there
is no longer room for protocol development. However,
improvements may be slow in coming because the high
cost and limited access to the NHP resource means that
relatively few programs will be able to participate. Yet
improvements in pregnancy rates should be anticipated
based on extrapolation from the clinical experience in
women where protocol development over the entire 20+
history of the technology has resulted in ever increasing
pregnancy and implantation rates. The current expecta-
tions include 50% pregnancy rates in patients under 35
and even higher levels when donor oocytes are used with
implantation efficiencies of 0.5/embryo transferred [34-
36]. How should we focus efforts in NHPs? This is a diffi-
cult challenge but selection of higher, and perhaps fewer,
quality oocytes following animal exposure to individual-
ized ovarian stimulation protocols seems a good place to
start. Although embryo development in HECM-9 was
improved over that obtained on coculture or in KSOM-
AA, it is likely that further improvements in embryo cul-
ture that translate into higher pregnancy rates are possi-
ble. Finally attention focused on embryo transfer is
appropriate both from a technical perspective, for
instance with regards to pH stability in the oviduct during
the insufflation required for laparoscopic ET, as well as
recipient selection based on parameters that have not yet
been developed but might reasonably include size, age,
parity, menstrual cycle regularity and systemic cortisol
level as an indirect measure of psychological health. From
a longer term perspective, it may be worthwhile to evalu-
ate the possible recovery and maturation of ovarian
oocytes from necropsy animals or perhaps even to derive
gametes from ES cells as has been accomplished in the
mouse [37,38].
Table 2: Live births and fetal loss for singleton pregnancies following application of the ARTs in rhesus macaques.
Pregnancy singleton
Embryo Type Live birth (%) SAB (%) SB (%)
NT 2/3 (67) - 1/3 (33)
ICSI 35/37a (95) - 2/37 (5)
IVF 17/19 (89) 2/19 (11) -
TW 9/13b (69) 2/13 (15) 2/13 (15)
TMB 171/185a (92) - 14/185 (8)
The results are from Wolf and coauthors [7]. NT nuclear transfer with embryonic blastomeres as donor nuclei ICSI intracytoplasmic sperm 
injection IVF conventional in vitro fertilization TW twinned embryos by blastomere separation TMB timed mated breeding colong SAB spontaneous 
abortion, fetal loss at <140 days SB still born, fetal loss >140 days Values with different superscripts are significantly different based on Chi squared 
analysisReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/37
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Before ending, a comment or two relative to cost effective-
ness of the ARTs in NHP is appropriate. Clearly, if there is
no other way to acquire specific animals i.e., they are
priceless, then this discussion is irrelevant. But consider
acquiring rhesus macaques of either Indian-origin from
local sources, if they are available at all, or Chinese-origin
Growth rates for ART-produced offspring Figure 5
Growth rates for ART-produced offspring. The average weight in kilograms for singleton (closed diamonds) and twin 
(closed square) offspring are plotted versus time in years. Results are compared to a group of singleton infants produced in the 
timed mated breeding colony (closed triangle) at ONPRC. Significant differences were observed between the singleton and 
twin offspring at birth and up until 1 year of age. Results are from Wolf and coauthors [7].
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from importers. The cost of the former have been esti-
mated at approximately $7,000 for a SPF, adult male and
for the latter, approximately $5,000/yearling or adult (G.
Heckman, personal communication). How much finan-
cial sense does it make then to use the ARTs in the context
of routine animal production? First off, the ARTs can't
compete with open corral housing and animal production
where infant costs reflect only per diem maintenance rates
at approximately $2,000 [7]. When considering the TMB
colony where animals are individually caged, per diem
increases dramatically and the cost per animal may
approach $5,000. For animal production by IVF or ICSI
and based on 30% pregnancy rates, the estimated cost per
animal is between $7,500 and $9,000. However, modest
improvements in outcome to 50% pregnancy rates fol-
lowing the transfer of 2 embryos can bring that cost down
to $4,000. This is based on the expectation that a single
controlled ovarian stimulation, oocyte collection, embryo
production cycle can support 7–8 embryo transfers and
3–4 offspring. The use of frozen sperm ICSI, where a sin-
gle ejaculate can provide adequate sperm for 100 oocyte
cohorts, reduces the male costs to an insignificant level.
Thus, the ARTs may soon be used extensively in the rou-
tine propagation of valuable animals. These considera-
tions assume that the technical support and the resources
already are in place and are based on modest subsidies for
ARTCore services at ONPRC. The logistics of providing
such services to the wider NHP community could involve
the use of one or more centralized facilities or a larger
number of local units.
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